Valuation: Apeloa Pharmaceutical Co.,Ltd

Market Cap 31.23B 4.66B 4.14B 3.86B 3.52B 6.64B 448B 6.7B 46.74B 18.11B 229B 17.49B 17.11B 735B P/E 2026 *
29x
P/E 2027 * 25.4x
Enterprise Value 30.71B 4.58B 4.07B 3.8B 3.46B 6.53B 440B 6.59B 45.97B 17.81B 225B 17.2B 16.82B 722B EV / Sales 2026 *
3.02x
EV / Sales 2027 * 2.38x
Free-Float
45.08%
Yield 2026 *
1.12%
Yield 2027 * 1.21%
1 day+4.44%
1 week+9.64%
1 month+29.02%
3 months+52.08%
6 months+57.61%
Current year+70.50%
1 week 24.96
Extreme 24.96
27.89
1 month 21.31
Extreme 21.31
27.89
Current year 15.19
Extreme 15.19
27.89
1 year 14.89
Extreme 14.89
27.89
3 years 10.66
Extreme 10.66
27.89
5 years 10.66
Extreme 10.66
41.87
10 years 4.86
Extreme 4.86
41.87
Manager TitleAgeSince
Chief Executive Officer 54 -
Director of Finance/CFO 54 -
President 52 -
Director TitleAgeSince
Director/Board Member 60 15/04/2005
Director/Board Member 61 16/05/2008
Chairman 54 07/11/2017
Date Insider Type Main position Quantity % Market Cap. Importance
26/04/23 Sell

Chief Executive Officer

6,200 0.0005%
28/06/22 Buy 50,000 0.0042%
28/06/22 Buy

Director

100,000 0.0085%
Change 5-day change 1-year change 3-year change Capi.($)
+4.44%+9.64%+69.35%+54.20% 4.66B
-0.61%-3.43%+36.07%+117.61% 1,019B
-1.02%-5.60%+35.72%+64.82% 617B
+1.11%-0.58%+12.36%+78.27% 464B
+0.34%-3.01%+61.79%+41.79% 356B
-0.95%-4.05%+20.54%+40.33% 333B
-1.46%-2.89%+10.57%+26.54% 267B
-1.35%-5.43%-6.17%+8.82% 244B
-1.04%-2.79%+35.30%+54.42% 218B
-1.87%-4.10%+28.44%+97.54% 179B
Average -0.24%-2.10%+30.40%+58.43% 370.18B
Weighted average by Cap. -0.59%-3.31%+29.12%+71.13%

Financials

2026 *2027 *
Net sales 10.19B 1.52B 1.35B 1.26B 1.15B 2.17B 146B 2.19B 15.25B 5.91B 74.66B 5.7B 5.58B 240B 11.39B 1.7B 1.51B 1.41B 1.28B 2.42B 163B 2.44B 17.04B 6.6B 83.46B 6.38B 6.24B 268B
Net income 1.11B 165M 147M 137M 125M 235M 15.86B 237M 1.66B 642M 8.11B 619M 606M 26.02B 1.26B 189M 168M 156M 143M 269M 18.13B 271M 1.89B 733M 9.27B 708M 693M 29.74B
Net Debt -516M -76.99M -68.41M -63.85M -58.2M -110M -7.4B -111M -773M -299M -3.78B -289M -283M -12.14B -4.15B -618M -549M -513M -467M -882M -59.45B -890M -6.21B -2.41B -30.39B -2.32B -2.27B -97.54B
Logo Apeloa Pharmaceutical Co.,Ltd
Apeloa Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Active Pharmaceutical Ingredient (API) intermediates, contract development and manufacturing organization (CDMO), preparations and others, as well as import and export trade. The Company operates three businesses. The API intermediates business mainly includes cephalosporin series, penicillin series, psychiatric series, cardiovascular and cerebrovascular series and veterinary API intermediates series. The CDMO business mainly includes research and development services, commercial human drug projects, commercial veterinary drug projects and other commercial products. The preparation business mainly includes anti-infective, cardiovascular and cerebrovascular, psychiatric and anti-tumor preparation products. The Company mainly operates its businesses in domestic and overseas markets.
Employees
6,787
Date Price Change Volume
30/09/26 CN¥27.74 +4.44% 21,579,866
29/09/26 CN¥26.56 -0.93% 17,767,079
28/09/26 CN¥26.81 +5.97% 22,178,254
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
27.74CNY
Average target price
24.07CNY
Spread / Average Target
-13.24%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 000739 Stock